145 related articles for article (PubMed ID: 2029406)
21. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias.
Alers JC; Krijtenburg PJ; Vissers KJ; Bosman FT; van der Kwast TH; van Dekken H
Genes Chromosomes Cancer; 1995 Apr; 12(4):241-50. PubMed ID: 7539277
[TBL] [Abstract][Full Text] [Related]
22. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer.
Badalament RA; O'Toole RV; Young DC; Drago JR
Cancer; 1991 Jun; 67(12):3014-23. PubMed ID: 1710533
[TBL] [Abstract][Full Text] [Related]
23. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.
Blute ML; Bergstralh EJ; Iocca A; Scherer B; Zincke H
J Urol; 2001 Jan; 165(1):119-25. PubMed ID: 11125379
[TBL] [Abstract][Full Text] [Related]
24. Seminal vesicle biopsy: accuracy and implications for staging of prostate cancer.
Linzer DG; Stock RG; Stone NN; Ratnow R; Ianuzzi C; Unger P
Urology; 1996 Nov; 48(5):757-61. PubMed ID: 8911521
[TBL] [Abstract][Full Text] [Related]
25. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.
Ross JS; Nazeer T; Figge HL; Fisher HA; Rifkin MD
Am J Clin Pathol; 1995 Jul; 104(1):36-41. PubMed ID: 7541934
[TBL] [Abstract][Full Text] [Related]
26. [Current value of seminal vesicle biopsy in patients with prostate cancer and influence of radical prostatectomy in patients with seminal vesicle invasion].
Losa CA; Fernando AB; Lázaro VA; Berlanga FF; Frago PS; López MA; Sanz MJ; Martínez PG; Sanz LA
Arch Esp Urol; 2006 Dec; 59(10):977-88. PubMed ID: 17283711
[TBL] [Abstract][Full Text] [Related]
27. A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer.
D'Amico AV; Whittington R; Malkowicz SB; Schnall M; Tomaszewski J; Schultz D; Kao G; VanArsdalen K; Wein A
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):293-302. PubMed ID: 7928457
[TBL] [Abstract][Full Text] [Related]
28. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression.
Salomon L; Anastasiadis AG; Johnson CW; McKiernan JM; Goluboff ET; Abbou CC; Olsson CA; Benson MC
Urology; 2003 Aug; 62(2):304-9. PubMed ID: 12893340
[TBL] [Abstract][Full Text] [Related]
29. The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate.
Mukamel E; deKernion JB; Hannah J; Smith RB; Skinner DG; Goodwin WE
Cancer; 1987 Apr; 59(8):1535-8. PubMed ID: 3815316
[TBL] [Abstract][Full Text] [Related]
30. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
[TBL] [Abstract][Full Text] [Related]
31. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer.
Bostwick DG; Qian J; Bergstralh E; Dundore P; Dugan J; Myers RP; Oesterling JE
J Urol; 1996 Apr; 155(4):1361-7. PubMed ID: 8632575
[TBL] [Abstract][Full Text] [Related]
32. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
J Urol; 1995 Jul; 154(1):131-8. PubMed ID: 7539857
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.
Lau WK; Blute ML; Bostwick DG; Weaver AL; Sebo TJ; Zincke H
J Urol; 2001 Nov; 166(5):1692-7. PubMed ID: 11586204
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric analysis of localized adenocarcinoma of the prostate: the use of archival DNA analysis in conjunction with pathological grading to predict clinical outcome following radical retropubic prostatectomy.
Ring KS; Karp FS; Olsson CA; O'Toole K; Bixon R; Benson MC
Prostate; 1990; 17(2):155-64. PubMed ID: 2399191
[TBL] [Abstract][Full Text] [Related]
35. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
Egan AJ; Bostwick DG
Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
Abaza R; Diaz LK; Laskin WB; Pins MR
J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199
[TBL] [Abstract][Full Text] [Related]
37. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases.
Sebo TJ; Cheville JC; Riehle DL; Lohse CM; Pankratz VS; Myers RP; Blute ML; Zincke H
Cancer; 2001 Jun; 91(11):2196-204. PubMed ID: 11391602
[TBL] [Abstract][Full Text] [Related]
38. Distal seminal vesicle invasion by prostate adenocarcinoma does not occur in isolation of proximal seminal vesicle invasion or lymphovascular infiltration.
Samaratunga H; Samaratunga D; Perry-Keene J; Adamson M; Yaxley J; Delahunt B
Pathology; 2010 Jun; 42(4):330-3. PubMed ID: 20438404
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric DNA analysis of stage D2 prostatic carcinoma.
Yokogi H; Mizutani M; Ishibe T
Urol Int; 1991; 47(2):57-9. PubMed ID: 1792707
[TBL] [Abstract][Full Text] [Related]
40. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
